A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain l...
Saved in:
Published in | Journal of medicinal chemistry Vol. 64; no. 3; pp. 1362 - 1391 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
11.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications. |
---|---|
AbstractList | Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications.Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications. Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC6 displays unique structure and cellular localization as well as diverse substrates and exhibits a wider range of biological functions than other isoforms. HDAC6 inhibitors have been effectively used to treat cancers, neurodegenerative diseases, and autoimmune disorders without exerting significant toxic effects. Progress has been made in defining the crystal structures of HDAC6 catalytic domains which has influenced the structure-based drug design of HDAC6 inhibitors. This review summarizes recent literature on HDAC6 inhibitors with particular reference to structural specificity and functional diversity. It may provide up-to-date guidance for the development of HDAC6 inhibitors and perspectives for optimization of therapeutic applications. |
Author | Ma, Li-Ying Khamis, Mussa Yussuf Liu, Hong-Min Qin-Ma Wu, Hui-Pan Zhang, Xin-Hui Li, Yi-Han |
AuthorAffiliation | China Meheco Topfond Pharmaceutical Co., Ltd Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences |
AuthorAffiliation_xml | – name: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences – name: China Meheco Topfond Pharmaceutical Co., Ltd |
Author_xml | – sequence: 1 givenname: Xin-Hui surname: Zhang fullname: Zhang, Xin-Hui organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences – sequence: 2 surname: Qin-Ma fullname: Qin-Ma organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences – sequence: 3 givenname: Hui-Pan surname: Wu fullname: Wu, Hui-Pan organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences – sequence: 4 givenname: Mussa Yussuf surname: Khamis fullname: Khamis, Mussa Yussuf organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences – sequence: 5 givenname: Yi-Han surname: Li fullname: Li, Yi-Han organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences – sequence: 6 givenname: Li-Ying orcidid: 0000-0002-7186-8259 surname: Ma fullname: Ma, Li-Ying email: maliying@zzu.edu.cn organization: China Meheco Topfond Pharmaceutical Co., Ltd – sequence: 7 givenname: Hong-Min orcidid: 0000-0001-6771-9421 surname: Liu fullname: Liu, Hong-Min email: liuhm@zzu.edu.cn organization: Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation; School of Pharmaceutical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33523672$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtPGzEUha2KqgTaf1BVXnYz6fVjHmGHoBQkpCJo16M7zp3GaDJOfT2g_PuaJnTRBaws65zPlr5zJA7GMJIQHxXMFWj1BR3P79e0dCtaz8GBqhv9RsxUqaGwDdgDMQPQutCVNofiiPkeAIzS5p04NKbUpqr1TMRTeUsPnh5l6OVNDL8iMUs_ykvPKX8ozwkdpe2ATLKSV-PKdz6FyBljwuhWJ_IuxcmlKeIg7zbkfO-dT1uJ41JeTKNLPow5OvcPFDkH78XbHgemD_vzWPy8-Prj7LK4_v7t6uz0ukCrbCoMNTW5rrGVrkprtcOlg66HDmunFTaq1gvsqgU0ZdmVttEIC9NXHWG-LDWYY_F59-4mht8TcWrXnh0NA44UJm61zaQyqlnk6qd9deqy0nYT_Rrjtn32lAt2V3AxMEfq_1UUtE9ztHmO9nmOdj9Hxk7-w7IZfBKSIvrhNRh28N80TDFb5JeRPzxJpa0 |
CitedBy_id | crossref_primary_10_1021_acs_jmedchem_2c00853 crossref_primary_10_1016_j_bmcl_2024_129670 crossref_primary_10_1021_acs_jmedchem_1c02067 crossref_primary_10_3390_ijms231710014 crossref_primary_10_1016_j_molstruc_2023_134952 crossref_primary_10_3390_ijms23179592 crossref_primary_10_3389_fphar_2022_1064485 crossref_primary_10_1021_acs_jmedchem_1c00966 crossref_primary_10_1080_0886022X_2024_2415517 crossref_primary_10_3390_ph18030351 crossref_primary_10_1016_j_ejmech_2021_113392 crossref_primary_10_1055_s_0042_1749373 crossref_primary_10_1021_acsmedchemlett_2c00081 crossref_primary_10_1021_acs_jmedchem_1c01897 crossref_primary_10_1080_13102818_2024_2362842 crossref_primary_10_26508_lsa_202201645 crossref_primary_10_1021_acs_jmedchem_4c00836 crossref_primary_10_1016_j_compbiolchem_2024_108051 crossref_primary_10_1080_07391102_2023_2272751 crossref_primary_10_3390_ijms23041961 crossref_primary_10_1021_acs_jmedchem_4c01168 crossref_primary_10_2174_0929867328666210902145102 crossref_primary_10_1016_j_ejmech_2024_116676 crossref_primary_10_3390_cells11233825 crossref_primary_10_1016_j_ejmech_2021_113825 crossref_primary_10_3390_molecules29194653 crossref_primary_10_1021_acsptsci_2c00004 crossref_primary_10_1016_j_ejmech_2021_113821 crossref_primary_10_1111_cbdd_14055 crossref_primary_10_1016_j_yexcr_2024_114126 crossref_primary_10_1021_acs_jmedchem_3c00977 crossref_primary_10_3390_ph18030341 crossref_primary_10_3390_molecules27103335 crossref_primary_10_4155_fmc_2021_0040 crossref_primary_10_1080_07391102_2022_2142668 crossref_primary_10_1016_j_jbc_2022_102800 crossref_primary_10_3389_fimmu_2023_1168848 crossref_primary_10_1248_bpb_b23_00603 crossref_primary_10_1016_j_bioorg_2023_106601 crossref_primary_10_1021_acs_jmedchem_3c01385 crossref_primary_10_1016_j_bioorg_2021_105278 crossref_primary_10_1021_acs_jmedchem_3c01345 crossref_primary_10_1002_jhet_4538 crossref_primary_10_1016_j_ejmech_2023_115673 crossref_primary_10_1002_cai2_114 crossref_primary_10_1016_j_ejmech_2023_115752 crossref_primary_10_1161_JAHA_121_024205 crossref_primary_10_1016_j_jscs_2022_101450 crossref_primary_10_1080_13543776_2025_2468792 crossref_primary_10_1021_acs_jmedchem_3c01269 crossref_primary_10_1002_ardp_202300208 crossref_primary_10_1021_acs_jcim_4c01052 crossref_primary_10_3390_pharmaceutics13111893 crossref_primary_10_1007_s00044_022_02987_8 crossref_primary_10_1371_journal_pone_0291779 crossref_primary_10_1016_j_bmcl_2021_128286 crossref_primary_10_1111_exd_14502 crossref_primary_10_1016_j_biopha_2023_114438 crossref_primary_10_1002_cmdc_202400194 crossref_primary_10_1016_j_ejmech_2024_116571 crossref_primary_10_1002_cbic_202100255 crossref_primary_10_1080_14756366_2023_2201408 crossref_primary_10_3390_ph17111536 crossref_primary_10_1016_j_ejmech_2021_113526 crossref_primary_10_1016_j_ejmech_2023_116057 crossref_primary_10_1016_j_ejmech_2023_115367 crossref_primary_10_1016_j_ejmech_2023_115327 crossref_primary_10_1016_j_jddst_2024_106238 crossref_primary_10_2139_ssrn_4195671 crossref_primary_10_1002_asia_202200575 crossref_primary_10_1016_j_ejmech_2022_115004 crossref_primary_10_1128_jvi_01814_23 crossref_primary_10_1016_j_ejphar_2022_175349 crossref_primary_10_1016_j_apsb_2022_09_022 crossref_primary_10_1021_acs_jmedchem_4c00541 crossref_primary_10_1080_14728222_2024_2404571 crossref_primary_10_1111_febs_16703 crossref_primary_10_1016_j_bioorg_2022_105874 crossref_primary_10_1021_acschembio_3c00212 crossref_primary_10_1016_j_compbiomed_2023_107036 crossref_primary_10_1021_acsmedchemlett_1c00425 crossref_primary_10_1016_j_bioorg_2024_107818 crossref_primary_10_1021_acs_jmedchem_2c01418 crossref_primary_10_1021_acs_jmedchem_3c01008 crossref_primary_10_1038_s41598_022_25390_0 crossref_primary_10_1016_j_ejmech_2021_113874 crossref_primary_10_1142_S2737416524500121 |
Cites_doi | 10.3892/or.2016.4811 10.1093/hmg/ddt402 10.1021/jm0506773 10.1016/j.bmc.2018.02.042 10.2174/1568026617666170707124126 10.1080/13880209.2018.1563620 10.1016/j.yjmcc.2018.10.007 10.1016/j.ejmech.2014.03.018 10.1021/acs.jmedchem.9b00946 10.1038/417455a 10.1021/acsmedchemlett.0c00395 10.1016/j.ejmech.2019.112016 10.1016/j.expneurol.2020.113281 10.1016/j.bmcl.2010.12.079 10.1158/2159-8290.CD-16-1020 10.1074/jbc.R112.372300 10.2217/epi.14.69 10.1016/j.bmcl.2006.04.091 10.1021/acs.jmedchem.8b00393 10.3892/ijo.2018.4405 10.3390/ijms20246213 10.1016/j.ejmech.2018.03.006 10.1016/j.bbamcr.2019.03.003 10.1073/pnas.0803749105 10.1038/nchembio.2134 10.1182/blood-2011-10-387365 10.1111/jnc.14849 10.1038/nchembio.1223 10.1016/j.brainresbull.2020.06.010 10.1016/j.phrs.2019.104281 10.1016/j.bmc.2018.10.022 10.1016/j.ejmech.2018.09.024 10.1021/acs.jmedchem.9b00924 10.1016/j.bmc.2017.06.001 10.1111/bjh.12384 10.1021/acsmedchemlett.0c00046 10.1002/cmdc.201500456 10.2174/1568026619666181129141822 10.1016/j.ejmech.2018.03.005 10.1016/j.ccr.2007.08.001 10.1016/j.gore.2019.07.010 10.1016/j.ajpath.2017.12.016 10.1038/nature07348 10.1016/j.phrs.2020.105274 10.1002/ejic.200400221 10.1371/journal.pone.0205018 10.1016/j.yjmcc.2019.04.003 10.1002/med.20056 10.1021/acs.jmedchem.5b01493 10.1016/j.ejmech.2020.112998 10.1016/j.ejmech.2020.112887 10.1021/acs.biochem.9b00934 10.1021/acs.jmedchem.9b00940 10.1021/acs.jmedchem.0c00628 10.1042/BSR20181916 10.1038/nchembio.2140 10.1021/jm990366q 10.1007/s10753-018-0853-0 10.1016/j.bmc.2019.06.036 10.1155/2011/875824 10.1016/j.biopha.2019.109357 10.1021/acs.jmedchem.7b01404 10.1016/j.bmcl.2018.06.037 10.1002/cmdc.201500486 10.1016/j.neuint.2016.08.004 10.1021/acs.jmedchem.0c00567 10.1021/acs.jmedchem.6b00157 10.1007/s13238-018-0602-z 10.1016/j.ejmech.2018.07.069 10.1016/j.bmc.2019.115250 10.1021/acschemneuro.8b00600 10.1038/s41419-018-0788-2 10.4149/gpb_2019058 10.1074/jbc.M111.273730 10.1002/mc.22852 10.1038/sj.onc.1203925 10.1021/acsmedchemlett.8b00487 10.1158/1078-0432.CCR-14-2820 10.1016/j.molcel.2005.04.021 10.1016/j.ejmech.2020.112086 10.1038/s41419-018-0688-5 10.1007/s002800100300 10.1021/acsmedchemlett.9b00084 10.1021/acs.jmedchem.0c00830 10.1021/acs.orglett.8b01118 10.1016/j.ejmech.2016.05.047 10.3390/antiox9070599 10.1021/acsomega.0c00559 10.1038/s41419-020-2586-x 10.1080/07391102.2018.1557560 10.1016/j.pharmthera.2017.02.027 10.1016/j.ejmech.2018.04.046 10.1080/13543776.2018.1526280 10.1016/j.bmcl.2020.127023 10.1073/pnas.1515882112 10.1021/jm020449y 10.1016/j.bmcl.2018.12.052 10.1016/j.ejmech.2020.112193 10.1002/cmdc.201700550 10.3892/ijo.2019.4739 10.1021/acs.jmedchem.9b01540 10.1007/s10495-020-01607-3 10.1021/acs.jmedchem.5b00099 10.1146/annurev.biochem.70.1.369 10.1021/acs.jmedchem.8b01936 10.1016/j.ejmech.2020.112679 10.1056/NEJMoa1513257 10.1016/j.ejmech.2016.03.046 10.3390/cancers11091327 10.1016/j.leukres.2020.106398 10.1080/13543776.2018.1508451 10.1016/j.molcel.2007.05.033 10.1016/j.biopha.2018.11.017 10.1021/acsmedchemlett.9b00560 10.1073/pnas.1718823114 10.1016/j.bmcl.2012.10.007 10.1073/pnas.1313893110 10.1182/blood-2006-06-025999 10.1016/j.bmc.2018.06.023 10.1038/leu.2017.322 10.1002/jcp.29776 10.1021/acs.jmedchem.8b01090 10.1016/j.taap.2019.03.017 10.1158/1535-7163.MCT-17-0603 10.1021/acschemneuro.9b00303 10.1021/acs.jmedchem.0c00193 10.3389/fphar.2019.00653 10.3390/ijms21134589 10.1038/nrd.2016.211 10.3390/ijms18050954 10.1038/nature05913 10.1007/s13311-016-0501-z 10.1073/pnas.0404603101 10.1158/0008-5472.CAN-18-0161 10.1039/C8OB00966J 10.1038/43710 10.1016/j.ejmech.2020.112868 10.1021/jm301098e 10.1021/acsmedchemlett.7b00012 10.1038/450357a 10.1182/blood-2009-04-214957 10.18632/oncotarget.19019 10.1042/CS20171417 10.1016/j.bmc.2018.05.013 10.1016/j.brainres.2020.146692 10.2147/DDDT.S124977 10.1016/j.semcancer.2020.02.006 10.1080/07391102.2016.1231084 10.1021/acs.jmedchem.8b01487 10.2174/0929867325666180327093502 10.1038/nrc1716 10.1371/journal.pone.0173507 10.1016/j.ejmech.2019.111950 10.1016/j.it.2011.04.001 10.1126/science.1172782 10.1016/j.ejmech.2017.10.040 10.1038/s41598-019-42237-3 10.1016/j.molonc.2015.04.002 10.1186/gb-2004-5-12-253 10.1186/s13075-020-02258-0 10.1080/13543776.2019.1708901 10.18632/oncotarget.13738 10.1021/jm200326p 10.1186/s13045-018-0654-9 10.1093/carcin/bgx121 10.1016/j.ijbiomac.2020.06.115 10.1021/jm8002894 10.5582/irdr.2016.01024 10.1186/s40425-019-0517-0 10.1007/s11596-019-2024-4 10.1016/j.cell.2007.02.005 10.1016/j.bcp.2019.03.023 10.1016/j.cell.2007.02.006 10.1021/acs.jmedchem.9b01888 10.1021/acsmedchemlett.7b00223 10.1038/s41375-020-0840-y 10.3390/nano10010161 10.1126/science.1179689 10.1002/jcb.26841 10.1021/acs.jmedchem.8b01590 10.1016/S1470-2045(15)00584-7 10.1021/ja102758v 10.1016/j.bmcl.2018.05.057 10.2174/092986712802884286 10.1021/acs.jmedchem.7b01593 10.1073/pnas.1608067113 10.1038/s41388-020-1172-0 10.1016/j.ejphar.2018.03.026 10.3390/cancers12030756 10.1073/pnas.96.9.4868 10.1152/ajprenal.00186.2017 10.1007/s11064-019-02882-6 10.3389/fnagi.2020.00078 10.1016/j.ejmech.2020.112831 |
ContentType | Journal Article |
Copyright | 2021 American Chemical
Society |
Copyright_xml | – notice: 2021 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1021/acs.jmedchem.0c01782 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1520-4804 |
EndPage | 1391 |
ExternalDocumentID | 33523672 10_1021_acs_jmedchem_0c01782 a838918514 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | - .K2 55A 5GY 5RE 5VS 7~N AABXI ABFLS ABMVS ABOCM ABPTK ABUCX ACGFS ACJ ACS AEESW AENEX AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CS3 DU5 EBS ED ED~ F5P GNL IH2 IH9 IHE JG JG~ K2 L7B LG6 P2P ROL TN5 UI2 VF5 VG9 W1F WH7 X XFK YZZ ZY4 --- -~X 4.4 6P2 AAHBH AAYXX ABBLG ABJNI ABLBI ABQRX ACGFO ADHLV AGXLV AHGAQ CITATION CUPRZ GGK XSW YQT ABTAH CGR CUY CVF ECM EIF NPM YIN 7X8 |
ID | FETCH-LOGICAL-a414t-3e87ecb846265442cadc0bf0ba7c21a81729ab690855b5482a093f6bea548d203 |
IEDL.DBID | ACS |
ISSN | 0022-2623 1520-4804 |
IngestDate | Fri Jul 11 13:23:55 EDT 2025 Wed Feb 19 02:29:16 EST 2025 Thu Apr 24 23:11:09 EDT 2025 Tue Jul 01 01:09:53 EDT 2025 Sat Feb 13 03:12:48 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | https://doi.org/10.15223/policy-029 https://doi.org/10.15223/policy-037 https://doi.org/10.15223/policy-045 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a414t-3e87ecb846265442cadc0bf0ba7c21a81729ab690855b5482a093f6bea548d203 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0001-6771-9421 0000-0002-7186-8259 |
PMID | 33523672 |
PQID | 2485513189 |
PQPubID | 23479 |
PageCount | 30 |
ParticipantIDs | proquest_miscellaneous_2485513189 pubmed_primary_33523672 crossref_primary_10_1021_acs_jmedchem_0c01782 crossref_citationtrail_10_1021_acs_jmedchem_0c01782 acs_journals_10_1021_acs_jmedchem_0c01782 |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-02-11 |
PublicationDateYYYYMMDD | 2021-02-11 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of medicinal chemistry |
PublicationTitleAlternate | J. Med. Chem |
PublicationYear | 2021 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref99/cit99 ref3/cit3 ref81/cit81 ref16/cit16 ref185/cit185 ref23/cit23 ref115/cit115 ref187/cit187 ref181/cit181 ref111/cit111 ref113/cit113 ref183/cit183 ref117/cit117 ref48/cit48 ref74/cit74 ref189/cit189 ref119/cit119 ref10/cit10 ref35/cit35 ref93/cit93 ref42/cit42 ref120/cit120 ref178/cit178 ref122/cit122 ref61/cit61 ref176/cit176 ref67/cit67 ref128/cit128 ref124/cit124 ref126/cit126 ref54/cit54 ref137/cit137 ref11/cit11 ref102/cit102 ref29/cit29 ref174/cit174 ref86/cit86 ref170/cit170 ref5/cit5 ref43/cit43 ref80/cit80 ref133/cit133 ref28/cit28 ref148/cit148 ref55/cit55 ref144/cit144 ref167/cit167 ref163/cit163 ref66/cit66 ref22/cit22 ref87/cit87 ref106/cit106 ref190/cit190 ref140/cit140 ref194/cit194 ref98/cit98 ref153/cit153 ref150/cit150 ref63/cit63 ref56/cit56 ref155/cit155 ref156/cit156 ref158/cit158 ref8/cit8 ref59/cit59 ref85/cit85 ref34/cit34 ref37/cit37 ref60/cit60 ref17/cit17 ref82/cit82 ref147/cit147 ref145/cit145 ref21/cit21 ref166/cit166 ref164/cit164 ref78/cit78 ref36/cit36 ref83/cit83 ref79/cit79 ref139/cit139 ref172/cit172 ref14/cit14 ref57/cit57 ref169/cit169 ref134/cit134 ref40/cit40 ref131/cit131 ref161/cit161 ref142/cit142 ref15/cit15 ref180/cit180 ref62/cit62 ref41/cit41 ref58/cit58 ref104/cit104 ref177/cit177 ref84/cit84 ref1/cit1 ref123/cit123 ref196/cit196 ref7/cit7 ref45/cit45 ref52/cit52 ref184/cit184 ref114/cit114 ref186/cit186 ref116/cit116 ref110/cit110 ref182/cit182 ref2/cit2 ref112/cit112 ref77/cit77 ref71/cit71 ref188/cit188 ref20/cit20 ref118/cit118 ref89/cit89 ref19/cit19 ref96/cit96 ref107/cit107 ref191/cit191 ref109/cit109 ref13/cit13 ref193/cit193 ref105/cit105 ref38/cit38 ref90/cit90 ref195/cit195 ref64/cit64 ref6/cit6 ref18/cit18 ref136/cit136 ref65/cit65 ref171/cit171 ref97/cit97 ref101/cit101 ref76/cit76 ref32/cit32 ref39/cit39 ref168/cit168 ref132/cit132 ref91/cit91 ref12/cit12 ref179/cit179 ref121/cit121 ref175/cit175 ref33/cit33 ref129/cit129 ref44/cit44 ref70/cit70 ref125/cit125 ref9/cit9 ref152/cit152 ref154/cit154 ref27/cit27 ref151/cit151 ref159/cit159 ref92/cit92 ref157/cit157 ref31/cit31 ref88/cit88 ref160/cit160 ref143/cit143 ref53/cit53 ref149/cit149 ref162/cit162 ref46/cit46 ref49/cit49 ref75/cit75 ref24/cit24 ref141/cit141 ref50/cit50 ref138/cit138 ref100/cit100 ref25/cit25 ref173/cit173 ref103/cit103 ref72/cit72 ref51/cit51 ref135/cit135 ref68/cit68 ref94/cit94 ref130/cit130 ref146/cit146 ref26/cit26 ref73/cit73 ref69/cit69 ref165/cit165 ref95/cit95 ref108/cit108 ref192/cit192 ref4/cit4 ref30/cit30 ref47/cit47 ref127/cit127 |
References_xml | – ident: ref82/cit82 doi: 10.3892/or.2016.4811 – ident: ref21/cit21 doi: 10.1093/hmg/ddt402 – ident: ref118/cit118 doi: 10.1021/jm0506773 – ident: ref114/cit114 doi: 10.1016/j.bmc.2018.02.042 – ident: ref94/cit94 doi: 10.2174/1568026617666170707124126 – ident: ref136/cit136 doi: 10.1080/13880209.2018.1563620 – ident: ref137/cit137 doi: 10.1016/j.yjmcc.2018.10.007 – ident: ref93/cit93 doi: 10.1016/j.ejmech.2014.03.018 – ident: ref180/cit180 doi: 10.1021/acs.jmedchem.9b00946 – ident: ref20/cit20 doi: 10.1038/417455a – ident: ref172/cit172 doi: 10.1021/acsmedchemlett.0c00395 – ident: ref173/cit173 doi: 10.1016/j.ejmech.2019.112016 – ident: ref164/cit164 doi: 10.1016/j.expneurol.2020.113281 – ident: ref86/cit86 doi: 10.1016/j.bmcl.2010.12.079 – ident: ref57/cit57 doi: 10.1158/2159-8290.CD-16-1020 – ident: ref12/cit12 doi: 10.1074/jbc.R112.372300 – ident: ref26/cit26 doi: 10.2217/epi.14.69 – ident: ref87/cit87 doi: 10.1016/j.bmcl.2006.04.091 – ident: ref181/cit181 doi: 10.1021/acs.jmedchem.8b00393 – ident: ref59/cit59 doi: 10.3892/ijo.2018.4405 – ident: ref153/cit153 doi: 10.3390/ijms20246213 – ident: ref99/cit99 doi: 10.1016/j.ejmech.2018.03.006 – ident: ref167/cit167 doi: 10.1016/j.bbamcr.2019.03.003 – ident: ref24/cit24 doi: 10.1073/pnas.0803749105 – ident: ref39/cit39 doi: 10.1038/nchembio.2134 – ident: ref53/cit53 doi: 10.1182/blood-2011-10-387365 – ident: ref56/cit56 doi: 10.1111/jnc.14849 – ident: ref186/cit186 doi: 10.1038/nchembio.1223 – ident: ref126/cit126 doi: 10.1016/j.brainresbull.2020.06.010 – ident: ref142/cit142 doi: 10.1016/j.phrs.2019.104281 – ident: ref152/cit152 doi: 10.1016/j.bmc.2018.10.022 – ident: ref106/cit106 doi: 10.1016/j.ejmech.2018.09.024 – ident: ref30/cit30 doi: 10.1021/acs.jmedchem.9b00924 – ident: ref113/cit113 doi: 10.1016/j.bmc.2017.06.001 – ident: ref16/cit16 doi: 10.1111/bjh.12384 – ident: ref191/cit191 doi: 10.1021/acsmedchemlett.0c00046 – ident: ref179/cit179 doi: 10.1002/cmdc.201500456 – ident: ref31/cit31 doi: 10.2174/1568026619666181129141822 – ident: ref177/cit177 doi: 10.1016/j.ejmech.2018.03.005 – ident: ref47/cit47 doi: 10.1016/j.ccr.2007.08.001 – ident: ref61/cit61 doi: 10.1016/j.gore.2019.07.010 – ident: ref64/cit64 doi: 10.1016/j.ajpath.2017.12.016 – ident: ref36/cit36 doi: 10.1021/acs.jmedchem.9b00946 – ident: ref6/cit6 doi: 10.1038/nature07348 – ident: ref70/cit70 doi: 10.1016/j.phrs.2020.105274 – ident: ref48/cit48 doi: 10.1002/ejic.200400221 – ident: ref112/cit112 doi: 10.1371/journal.pone.0205018 – ident: ref10/cit10 doi: 10.1016/j.yjmcc.2019.04.003 – ident: ref13/cit13 doi: 10.1002/med.20056 – ident: ref176/cit176 doi: 10.1021/acs.jmedchem.5b01493 – ident: ref157/cit157 doi: 10.1016/j.ejmech.2020.112998 – ident: ref45/cit45 doi: 10.1016/j.ejmech.2020.112887 – ident: ref41/cit41 doi: 10.1021/acs.biochem.9b00934 – ident: ref97/cit97 doi: 10.1021/acs.jmedchem.9b00940 – ident: ref121/cit121 doi: 10.1021/acs.jmedchem.0c00628 – ident: ref131/cit131 doi: 10.1042/BSR20181916 – ident: ref40/cit40 doi: 10.1038/nchembio.2140 – ident: ref49/cit49 doi: 10.1021/jm990366q – ident: ref139/cit139 doi: 10.1007/s10753-018-0853-0 – ident: ref92/cit92 doi: 10.1016/j.bmc.2019.06.036 – ident: ref25/cit25 doi: 10.1155/2011/875824 – ident: ref69/cit69 doi: 10.1016/j.biopha.2019.109357 – ident: ref165/cit165 doi: 10.1021/acs.jmedchem.7b01404 – ident: ref105/cit105 doi: 10.1016/j.bmcl.2018.06.037 – ident: ref158/cit158 doi: 10.1002/cmdc.201500486 – ident: ref124/cit124 doi: 10.1016/j.neuint.2016.08.004 – ident: ref133/cit133 doi: 10.1021/acs.jmedchem.0c00567 – ident: ref104/cit104 doi: 10.1021/acs.jmedchem.6b00157 – ident: ref196/cit196 doi: 10.1007/s13238-018-0602-z – ident: ref171/cit171 doi: 10.1016/j.ejmech.2018.07.069 – ident: ref182/cit182 doi: 10.1016/j.bmc.2019.115250 – ident: ref163/cit163 doi: 10.1021/acschemneuro.8b00600 – ident: ref55/cit55 doi: 10.1038/s41419-018-0788-2 – ident: ref84/cit84 doi: 10.4149/gpb_2019058 – ident: ref19/cit19 doi: 10.1074/jbc.M111.273730 – ident: ref89/cit89 doi: 10.1002/mc.22852 – ident: ref101/cit101 doi: 10.1038/sj.onc.1203925 – ident: ref183/cit183 doi: 10.1021/acsmedchemlett.8b00487 – ident: ref193/cit193 doi: 10.1158/1078-0432.CCR-14-2820 – ident: ref23/cit23 doi: 10.1016/j.molcel.2005.04.021 – ident: ref100/cit100 doi: 10.1016/j.ejmech.2020.112086 – ident: ref166/cit166 doi: 10.1038/s41419-018-0688-5 – ident: ref8/cit8 doi: 10.1007/s002800100300 – ident: ref154/cit154 doi: 10.1021/acsmedchemlett.9b00084 – ident: ref11/cit11 doi: 10.1021/acs.jmedchem.0c00830 – ident: ref170/cit170 doi: 10.1021/acs.orglett.8b01118 – ident: ref17/cit17 doi: 10.1016/j.ejmech.2016.05.047 – ident: ref141/cit141 doi: 10.3390/antiox9070599 – ident: ref185/cit185 doi: 10.1021/acsomega.0c00559 – ident: ref28/cit28 doi: 10.1038/s41419-020-2586-x – ident: ref81/cit81 doi: 10.1080/07391102.2018.1557560 – ident: ref190/cit190 doi: 10.1016/j.pharmthera.2017.02.027 – ident: ref148/cit148 doi: 10.1016/j.ejmech.2018.04.046 – ident: ref174/cit174 doi: 10.1080/13543776.2018.1526280 – ident: ref44/cit44 doi: 10.1016/j.bmcl.2020.127023 – ident: ref127/cit127 doi: 10.1073/pnas.1515882112 – ident: ref115/cit115 doi: 10.1021/jm020449y – ident: ref120/cit120 doi: 10.1016/j.bmcl.2018.12.052 – ident: ref168/cit168 doi: 10.1016/j.ejmech.2020.112193 – ident: ref175/cit175 doi: 10.1002/cmdc.201700550 – ident: ref145/cit145 doi: 10.3892/ijo.2019.4739 – ident: ref43/cit43 doi: 10.1021/acs.jmedchem.9b01540 – ident: ref76/cit76 doi: 10.1007/s10495-020-01607-3 – ident: ref116/cit116 doi: 10.1021/acs.jmedchem.5b00099 – ident: ref110/cit110 doi: 10.1146/annurev.biochem.70.1.369 – ident: ref146/cit146 doi: 10.1021/acs.jmedchem.8b01936 – ident: ref192/cit192 doi: 10.1016/j.ejmech.2020.112679 – ident: ref119/cit119 doi: 10.1056/NEJMoa1513257 – ident: ref91/cit91 doi: 10.1016/j.ejmech.2016.03.046 – ident: ref62/cit62 doi: 10.3390/cancers11091327 – ident: ref90/cit90 doi: 10.1016/j.leukres.2020.106398 – ident: ref187/cit187 doi: 10.1080/13543776.2018.1508451 – ident: ref22/cit22 doi: 10.1016/j.molcel.2007.05.033 – ident: ref68/cit68 doi: 10.1016/j.biopha.2018.11.017 – ident: ref135/cit135 doi: 10.1021/acsmedchemlett.9b00560 – ident: ref42/cit42 doi: 10.1073/pnas.1718823114 – ident: ref109/cit109 doi: 10.1016/j.bmcl.2012.10.007 – ident: ref123/cit123 doi: 10.1073/pnas.1313893110 – ident: ref15/cit15 doi: 10.1182/blood-2006-06-025999 – ident: ref50/cit50 doi: 10.1016/j.bmc.2018.06.023 – ident: ref75/cit75 doi: 10.1038/leu.2017.322 – ident: ref96/cit96 doi: 10.1002/jcp.29776 – ident: ref169/cit169 doi: 10.1021/acs.jmedchem.8b01090 – ident: ref83/cit83 doi: 10.1016/j.taap.2019.03.017 – ident: ref60/cit60 doi: 10.1158/1535-7163.MCT-17-0603 – ident: ref155/cit155 doi: 10.1021/acschemneuro.9b00303 – ident: ref156/cit156 doi: 10.1021/acs.jmedchem.0c00193 – ident: ref65/cit65 doi: 10.3389/fphar.2019.00653 – ident: ref125/cit125 doi: 10.3390/ijms21134589 – ident: ref188/cit188 doi: 10.1038/nrd.2016.211 – ident: ref143/cit143 doi: 10.3390/ijms18050954 – ident: ref1/cit1 doi: 10.1038/nature05913 – ident: ref67/cit67 doi: 10.1007/s13311-016-0501-z – ident: ref51/cit51 doi: 10.1073/pnas.0404603101 – ident: ref58/cit58 doi: 10.1158/0008-5472.CAN-18-0161 – ident: ref162/cit162 doi: 10.1039/C8OB00966J – ident: ref52/cit52 doi: 10.1038/43710 – ident: ref122/cit122 doi: 10.1016/j.ejmech.2020.112868 – ident: ref128/cit128 doi: 10.1021/jm301098e – ident: ref184/cit184 doi: 10.1021/acsmedchemlett.7b00012 – ident: ref2/cit2 doi: 10.1038/450357a – ident: ref108/cit108 doi: 10.1182/blood-2009-04-214957 – ident: ref78/cit78 doi: 10.18632/oncotarget.19019 – ident: ref138/cit138 doi: 10.1042/CS20171417 – ident: ref178/cit178 doi: 10.1016/j.bmc.2018.05.013 – ident: ref29/cit29 doi: 10.1016/j.brainres.2020.146692 – ident: ref151/cit151 doi: 10.2147/DDDT.S124977 – ident: ref189/cit189 doi: 10.1016/j.semcancer.2020.02.006 – ident: ref80/cit80 doi: 10.1080/07391102.2016.1231084 – ident: ref149/cit149 doi: 10.1021/acs.jmedchem.8b01487 – ident: ref103/cit103 doi: 10.2174/0929867325666180327093502 – ident: ref95/cit95 doi: 10.1038/nrc1716 – ident: ref74/cit74 doi: 10.1371/journal.pone.0173507 – ident: ref159/cit159 doi: 10.1016/j.ejmech.2019.111950 – ident: ref9/cit9 doi: 10.1016/j.it.2011.04.001 – ident: ref3/cit3 doi: 10.1126/science.1172782 – ident: ref46/cit46 doi: 10.1016/j.ejmech.2017.10.040 – ident: ref130/cit130 doi: 10.1038/s41598-019-42237-3 – ident: ref35/cit35 doi: 10.1016/j.molonc.2015.04.002 – ident: ref102/cit102 doi: 10.1186/gb-2004-5-12-253 – ident: ref33/cit33 doi: 10.1186/s13075-020-02258-0 – ident: ref32/cit32 doi: 10.1080/13543776.2019.1708901 – ident: ref54/cit54 doi: 10.18632/oncotarget.13738 – ident: ref107/cit107 doi: 10.1021/jm200326p – ident: ref27/cit27 doi: 10.1186/s13045-018-0654-9 – ident: ref88/cit88 doi: 10.1093/carcin/bgx121 – ident: ref98/cit98 doi: 10.1016/j.ijbiomac.2020.06.115 – ident: ref79/cit79 doi: 10.1021/jm8002894 – ident: ref14/cit14 doi: 10.5582/irdr.2016.01024 – ident: ref72/cit72 doi: 10.1186/s40425-019-0517-0 – ident: ref85/cit85 doi: 10.1007/s11596-019-2024-4 – ident: ref4/cit4 doi: 10.1016/j.cell.2007.02.005 – ident: ref161/cit161 doi: 10.1016/j.bcp.2019.03.023 – ident: ref5/cit5 doi: 10.1016/j.cell.2007.02.006 – ident: ref150/cit150 doi: 10.1021/acs.jmedchem.9b01888 – ident: ref38/cit38 doi: 10.1007/s13238-018-0602-z – ident: ref132/cit132 doi: 10.1021/acsmedchemlett.7b00223 – ident: ref71/cit71 doi: 10.1038/s41375-020-0840-y – ident: ref129/cit129 doi: 10.3390/nano10010161 – ident: ref7/cit7 doi: 10.1126/science.1179689 – ident: ref144/cit144 doi: 10.1002/jcb.26841 – ident: ref160/cit160 doi: 10.1021/acs.jmedchem.8b01590 – ident: ref194/cit194 doi: 10.1016/S1470-2045(15)00584-7 – ident: ref134/cit134 doi: 10.1021/ja102758v – ident: ref37/cit37 doi: 10.1016/j.bmcl.2018.05.057 – ident: ref111/cit111 doi: 10.2174/092986712802884286 – ident: ref147/cit147 doi: 10.1021/acs.jmedchem.7b01593 – ident: ref77/cit77 doi: 10.1073/pnas.1608067113 – ident: ref73/cit73 doi: 10.1038/s41388-020-1172-0 – ident: ref117/cit117 doi: 10.1016/j.ejphar.2018.03.026 – ident: ref195/cit195 doi: 10.3390/cancers12030756 – ident: ref18/cit18 doi: 10.1073/pnas.96.9.4868 – ident: ref63/cit63 doi: 10.1152/ajprenal.00186.2017 – ident: ref66/cit66 doi: 10.1007/s11064-019-02882-6 – ident: ref140/cit140 doi: 10.3389/fnagi.2020.00078 – ident: ref34/cit34 doi: 10.1016/j.ejmech.2020.112831 |
SSID | ssj0003123 |
Score | 2.6097264 |
SecondaryResourceType | review_article |
Snippet | Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1362 |
SubjectTerms | Animals Histone Deacetylase 6 - antagonists & inhibitors Histone Deacetylase Inhibitors - chemistry Histone Deacetylase Inhibitors - pharmacology Histone Deacetylase Inhibitors - therapeutic use Histone Deacetylases - chemistry Humans Models, Molecular Structure-Activity Relationship |
Title | A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity |
URI | http://dx.doi.org/10.1021/acs.jmedchem.0c01782 https://www.ncbi.nlm.nih.gov/pubmed/33523672 https://www.proquest.com/docview/2485513189 |
Volume | 64 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS9xAFB7EPuhLba3WW8sRRCiYNZkkk4xvy-qigu3CKvgWzkwmuF6imPVh--t7ZpLsYkXUx4TMMNdzyfnOdxjbwTzVCaLwjE6VFyksPEVi0NN5nBihApO40glnv8XxRXR6GV_OHMX_I_g82Eddda4tWPHK3HV8bcvJk8j9xEWaWGer2xtOJW8Y8LBlB-ek19tUuVd6sQpJV88V0itWptM2_SX2p83ZqUEmN52nserovy8pHN85kS_sc2N4Qrc-KV_ZnCmX2UKvrfe2zHYHNYv1ZA_OZ0lZ1R7swmDGbz35xh67UEcU4L6AgcV3kbSEUQmOcqQ0cEhi1ownZJcbEHBSXo3UyBb1gRbmdwBDR1trKT9g-GAcLpDcAcAyhz5p2voHJRy2oJEVdtE_Ou8de03pBg-jIBp7oUkToxUZN1zEUcQ15tpXha8w0TzAlMwmiYo88zSOFTlNHH0ZFkIZpIec--Eqmy9pxGsMyB8is4gcgSiXkUSJKHOZKi1VLFQRy3X2i1Y2a65elbmoOg8y97JZ7qxZ7nUWtnud6YYD3ZbiuH2jlTdt9VBzgLzx_XZ7jDLaQxuBwdLcP1WZ448LSIzSqL_X52vao01-C0XCNz4wn022yC3GxhaoCbbYPO2d-UFG0lj9dDfjHzkdD6o |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9tAEB5FcIALUCgU6GMqVUhIONjr5_YWhUahPBQpAXGzdtdrkQIG4eQQfn1n13aiVkKIo1fe1XofM994Zr4B-CGyRMVCRI5WiXQCKXJHkhh0VBbGOpKejm3phIvLqH8V_L4Jb1oQNrkwNImSRiqtE3_BLuAdm7Y_JmbxVj-0XWWqypPkXSY8wozN1ekO5wLY95jfkIQzUu9Nxtwroxi9pMp_9dIrYNMqnd46XM-na2NN7trTiWyrl_-YHN_9PRuwVsNQ7FTn5gO0dLEJK92m-tsmHAwqTuvZEY4WKVrlER7gYMF2PduC5w5W_gV8zHFgor1IduK4QEtAUmg8IaGrJzNC6RojPC1ux3JsSvxgE_T3E4eWxNYQgODwSdsoQTIOUBQZ9kjvVr8r8aQJIfkIV71fo27fqQs5OCLwgonj6yTWShLUYVEYBEyJTLkyd6WIFfNEQiCKC0l2ehKGkkwoJlzu55HUgh4y5vrbsFTQjD8BknVEIInMgiDjARdcCJ7xRCouw0jmId-FQ1rZtL6IZWp97MxLbWO93Gm93LvgN1ueqpoR3RTmuH-jlzPv9VQxgrzx_vfmNKW0h8YfIwr9OC1TyybnkVClWe9Ux2w-okmF86OY7b3je77BSn90cZ6en16e7cMqM9E3pnSN9xmWaB_1F4JPE_nVXpa_x5AYCw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEA6ioL5439cIIgh2bdMzvi27Lt4srIL4UpI0xfWoi10f1l_vJG3XA0T0saEJ0xxzdCbfR8gOTyIZch5YSkbC8gRPLYFq0JKJH6pAOCo01AkXl8HxtXd64998ovpCIXIcKTdJfH2qe0laIgw4B7r9Xtct3qmnmi01szxq3zGdudNxV73RGSph16FuBRRO0cRXt-Z-GEXbJpl_tU0_OJzG8LSmye1QZFNv8lB77YuafPuG5vivb5ohU6U7CvVi_8ySEZXNkYlGxQI3R3bbBbb1YB-uPq5q5fuwC-0P1OvBPHmpQ5FngOcU2rrqC3UodDMwQCSZgiYqX9UfoLeuIICT7K4ruprqB6riv0PoGDBbDQQCnZ4y1YIYJADPEmih_S1-W0KzKiVZINeto6vGsVUSOljcc7y-5aooVFKgy0MD3_Oo5Im0RWoLHkrq8AidKcYFxuuR7wsMpSi3mZsGQnF8SKjtLpLRDCVeJoBREjpLGB54CfMYZ5yzhEVCMuEHIvXZCtnDmY3LA5nHJtdOndg0ltMdl9O9Qtxq2WNZIqNrgo7HX3pZw169Ahnkl_e3qx0V4xrqvAzP1PNrHhtUOQeVK0q9VGy14Yj6SpwbhHT1D9-zRcbbzVZ8fnJ5tkYmqS7C0Qw2zjoZxWVUG-hF9cWmOS_vt-Iajg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Review+of+Progress+in+Histone+Deacetylase+6+Inhibitors+Research%3A+Structural+Specificity+and+Functional+Diversity&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Zhang%2C+Xin-Hui&rft.au=Qin-Ma&rft.au=Wu%2C+Hui-Pan&rft.au=Khamis%2C+Mussa+Yussuf&rft.date=2021-02-11&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=64&rft.issue=3&rft.spage=1362&rft.epage=1391&rft_id=info:doi/10.1021%2Facs.jmedchem.0c01782&rft.externalDBID=n%2Fa&rft.externalDocID=10_1021_acs_jmedchem_0c01782 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon |